Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 71 citing articles:

Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
Charles F. Zorumski, Steven M. Paul, Douglas F. Covey, et al.
Neurobiology of Stress (2019) Vol. 11, pp. 100196-100196
Open Access | Times Cited: 282
Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders
Thomas D. Prévot, Etienne Sibille
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 151-167
Closed Access | Times Cited: 190
Zuranolone for the Treatment of Postpartum Depression
Kristina M. Deligiannidis, Samantha Meltzer‐Brody, Bassem Maximos, et al.
American Journal of Psychiatry (2023) Vol. 180, Iss. 9, pp. 668-675
Closed Access | Times Cited: 98
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
Andrew J. Cutler, Gregory W. Mattingly, Vladimir Maletic
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 60
GABAA receptors as targets for treating affective and cognitive symptoms of depression
Bernhard Lüscher, Jamie Maguire, Uwe Rudolph, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 9, pp. 586-600
Open Access | Times Cited: 50
Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
Samantha Meltzer‐Brody, Stephen Kanes
Neurobiology of Stress (2020) Vol. 12, pp. 100212-100212
Open Access | Times Cited: 102
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator
Alison L. Althaus, Michael A. Ackley, Gabriel M. Belfort, et al.
Neuropharmacology (2020) Vol. 181, pp. 108333-108333
Open Access | Times Cited: 101
Is Postpartum Depression Different From Depression Occurring Outside of the Perinatal Period? A Review of the Evidence
Melissa M. Batt, Korrina A. Duffy, Andrew M. Novick, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2020) Vol. 18, Iss. 2, pp. 106-119
Open Access | Times Cited: 98
Allopregnanolone-based treatments for postpartum depression: Why/how do they work?
Najah Walton, Jamie Maguire
Neurobiology of Stress (2019) Vol. 11, pp. 100198-100198
Open Access | Times Cited: 89
The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
Felipe Borges Almeida, Graziano Pinna, Helena Maria Tannhauser Barros
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5495-5495
Open Access | Times Cited: 78
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
Thomas McGrath, Richard Baskerville, Marcelo Macedo Rogero, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 917-917
Open Access | Times Cited: 54
Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program
C. Neill Epperson, David R. Rubinow, Samantha Meltzer‐Brody, et al.
Journal of Affective Disorders (2022) Vol. 320, pp. 353-359
Open Access | Times Cited: 45
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
Delia Belelli, Derk J. Hogenkamp, Kelvin W. Gee, et al.
Neurobiology of Stress (2019) Vol. 12, pp. 100207-100207
Open Access | Times Cited: 55
Looking for Novelty in an “Old” Receptor: Recent Advances Toward Our Understanding of GABAARs and Their Implications in Receptor Pharmacology
David Castellano, Ryan D. Shepard, Wei Lü
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 46
Behavioral Deficits Induced by Somatostatin-Positive GABA Neuron Silencing Are Rescued by Alpha 5 GABA-A Receptor Potentiation
Corey Fee, Thomas D. Prévot, Keith A. Misquitta, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 24, Iss. 6, pp. 505-518
Open Access | Times Cited: 46
Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders
Autumn Walkerly, Lauren D. Leader, Emily Cooke, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3017-3026
Open Access | Times Cited: 41
The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins
Felipe Borges Almeida, Maurício Schüler Nin, Helena Maria Tannhauser Barros
Neurobiology of Stress (2020) Vol. 12, pp. 100218-100218
Open Access | Times Cited: 43
Allopregnanolone in mood disorders: Mechanism and therapeutic development
Shiyi Chen, Lijuan Gao, Xiaoyu Li, et al.
Pharmacological Research (2021) Vol. 169, pp. 105682-105682
Closed Access | Times Cited: 38
Allopregnanolone in Postpartum Depression
Graziano Pinna, Felipe Borges Almeida, John M. Davis
Frontiers in Global Women s Health (2022) Vol. 3
Open Access | Times Cited: 25
Progesterone Promotes Anti-anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice
Cheryl A. Frye, Don W. Cleveland, Anjali Sadarangani, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1173-1173
Open Access
New Directions in Neurosteroid Therapeutics in Neuropsychiatry
Charles F. Zorumski, Douglas F. Covey, Yukitoshi Izumi, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106119-106119
Open Access
Brexanolone to Treat Postpartum Depression in Adult Women.
Elyse M. Cornett, Lauren Rando, Austin M Labbé, et al.
PubMed (2021) Vol. 51, Iss. 2, pp. 115-130
Closed Access | Times Cited: 28
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Courtney M. Vecera, Alan C. Courtes, Gregory Jones, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1572-1572
Open Access | Times Cited: 12
The emergence of antidepressant drugs targeting GABAA receptors: A concise review
Xénia Gonda, Frank I. Tarazi, Péter Döme
Biochemical Pharmacology (2024) Vol. 228, pp. 116481-116481
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top